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In hormone-free xplant cultures of l&day fetal rat lung the levels of the mRNAs for fatty acid synthase, ATP citrate lyase and surfactant proteins 
A. B, and C, increased as they do m vivo. Also CTP:phosphocholine cytidylyltransferase mRNA increased spontaneously. Unlike in viva. malic 
enzyme mRNA increased drastically in cultured explants. Culture with dexamethasone increased the abundance of fatty acid synthase and surfactant 
protein mRNAs. but constderably depressed that of malic enzyme mRNA. Dexamethasone had little effect on CTP:phosphocholine cytidylyltrans- 
ferase mRNA. supporting the concept that the increased activity of this enzyme caused by glucocortrcoid is due to increased fatty acid synthesis. 
Lung surfactant. Glucocortlcoid; Lipogenic enzyme; Fatty acid synthase; CTP:phosphocholine cytidylyltransferase; Surfactant protem 
1. INTRODUCTION 
Pulmonary surfactant, a surface-active material pre- 
venting alveolar collapse and transudation, is produced 
by the type II alveolar epithelial cells [l]. It contains 
70-80% phospholipids and 5-10% proteins. Dipalmi- 
toylphosphatidylcholine is the major phospholipid 
component [l]. Four surfactant proteins have been de- 
scribed: the hydrophilic glycoproteins, SP-A and SP-D, 
and the hydrophobic proteins, SP-B and SP-C [2]. The 
synthesis of the surfactant in fetal type II cells starts in 
the terminal part of gestation and dramatically acceler- 
ates in the late prenatal period [3]. Results from many 
studies indicate that endogenous glucocorticoids are in- 
volved in the acceleration of surfactant synthesis [4]. In 
accordance with this idea, exposure of fetal lung in vivo 
or in explant culture to glucocorticoid leads to increased 
synthesis of surfactant components [2,4,5]. In lung ex- 
plant cultures, glucocorticoid increases the activity of 
fatty acid synthesis de novo [6] and of the enzymes fatty 
acid synthase (FAS) [6,7] and CTP:phosphocholine 
cytidylyltransferase (CPCT) [8,9]. The latter catalyzes a 
rate-regulatory step in phosphatidylcholine formation. 
Despite the large body of evidence demonstrating that 
glucocorticoids can accelerate the formation of surfac- 
tant components, results from several studies have indi- 
cated that this acceleration also occurs in the absence 
of glucocorticoids and in the presense of the glucocorti- 
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coid antagonist, RU 486; the glucocorticoids appear to 
exert a modulating, rather than an initiating, effect on 
lung maturation [4]. 
In the present investigation, explants of fetal rat lung 
tissue were cultured in serum-free medium. A character- 
istic of this culture system, in which it differs from cul- 
ture systems involving isolated cells, is that native cell- 
to-cell interactions are maintained. The first goal was to 
study the spontaneous development, which is influenced 
by factors endogenous to the lung, of the mRNAs cod- 
ing for CPCT and for FAS, and three other enzymes 
involved in fatty acid synthesis, acetyl-CoA carboxylase 
(ACC), ATP citrate lyase (ACL) and malic enzyme 
(ME). The second goal was to investigate the additional 
effect of dexamethasone on the levels of the various 
mRNAs. The third goal was to compare the spontane- 
ous and dexamethasone-induced changes in the abun- 
dance of the mRNAs of these lipid-synthesizing en- 
zymes with those occurring in the levels of the mRNAs 
coding for surfactant proteins. 
2. MATERIALS AND METHODS 
2.1. Materials 
The followmg plasmrds were used to make probes for Northern blot 
hybridization analysis: clone ~18.1-6 (0.5 kb msert encoding rat mam- 
mary gland ACC). clone pFAS-5 (1.1 kb insert encoding mouse liver 
FAS [lo]), clone pACL2 (1.5 kb insert encoding mouse liver ACL 
[l l]), clone pR ME1 (2.4 kb insert encoding rat liver mahc enzyme 
[12]), a clone containing a 1.3 kb insert encoding rat hver CPCT [13], 
clone pHFpA-3’UT-HF (0.4 kb insert encoding human P-cytoplasmic 
actm [14]). a clone containing a 663-bp insert encoding rat lung SP-A 
[15], clone SP-B 4-3 (1.8 kb insert encoding human SP-B [16] and clone 
RJ2-1 (0.8 kb insert encodmg human SP-C [17]. [a-“‘P]dATP (3,000 
Cilmmol) was obtained from New England Nuclear (Wilmington, 
DE). Pregnant Wrstar rats of known gestation trme (term IS at day 22) 
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were obtamed From the Central Animal Laboratory. Utrecht Umver- 
s1ty. 
Fetal rat lung explants were cultured as described by Gross et al. 
[18]. Briefly, lungs obtamed under sterile conditions from rat fetuses 
at day 18 of gestation were chopped mto l-mm’ cubes. The cubes were 
placed m 60-mm tissue culture dishes containing 2 ml serum-free 
Waymouth MB 753/l medium (Gibco, Paisley. Scotland) containing 
penicillin (100 U/ml) and streptomycin (100 peg/ml), and were mcu- 
bated on a rocking platform under an atmosphere of 5% CO: /95% 
air at 37°C for 48 h m the presence or absence of 100 nM dexa- 
methasone. 
2.3. isolation und Northern blot hybridixtion of RNA 
At the end of the culture period. the explants were scraped from the 
dishes with a rubber pohceman. rinsed twice with 0.9% NaCl. quickly 
frozen m liquid nitrogen and stored at -70°C. From this material the 
RNA was isolated by the guanidine isothiocyanatelCsC1 method [19]. 
RNA was quantified by measuring the absorbance at 260 nm. Ah- 
quots containing 30 pg total RNA were resolved by electrophoresis 
through a 1.2% agarose-formaldehyde gel [20]. After the separation 
the RNA was transferred to nylon membrane (Nytran-N, Schlelcher 
and Schuell, ‘s-Hertogenbosch. The Netherlands) by capillary blot- 
ting. Staming with Methylene blue showed that equal amounts of 
RNA were present on the blot m each lane. The blots were heated at 
80°C for 2 h. They were prehybridlzed for 3 h and subsequently 
hybridized for 1618 h as described [21 J using 0.25 pup “P-labeled 
cDNA. The “P-labeled probes (approx. 4 x 10’ cpmlpg DNA) were 
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prepared by random priming [?2] from [a-“P]dATP and cDNA inserts 
that had been excised from the plasmlds with the appropriate restric- 
tion enzymes. After hybridization the blots were washed [21] and 
autoradiograms of the blots were made at -80°C. The intensities of 
the hybrldlzation signals on the autoradiograms were quantified by 
densitometry. using an LKB Ultroscan XL laser densitometer. 
RESULTS 
3.1. Abundunce of the mRNAs encoding lipid-synthesiz- 
ing enzymes and srlrfuctant proteins as a flmction of 
culture time 
In order to study whether, in the absence of ex- 
ogenous hormones, fetal lung tissue maintained in ex- 
plant culture was able to pursue its normal differentia- 
tion process as far as changes in the mRNAs for FAS, 
ACC, ACL, ME, CPCT and surfactant proteins was 
concerned, we measured the abundance of the various 
mRNAs in lung explants after different culture times. 
Fig. I shows that the content of mRNA encoding FAS 
and ME increased drastically in culture, to 600% and 
SOO%, respectively, after 48 h. For ME mRNA the in- 
crease was already significant after 4 h of culture. The 
CPCT mRNAs also increased in abundance. although 
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Fig. 1. Relative abundance of mRNAs encoding lipid synthesizmg enzymes and /?-actin in fetal rat lung explants as a function of culture time. For 
each experiment the abundance of a particular mRNA was expressed as a percentage of the abundance at t = 0 h. Data represent means ? S.E.M. 
of 4 Independent experiments. Significantly different from value at t = 0 h according to Student’s t-test: ‘D.075 < P < 0.05. “0.01 < P < 0 025. 
‘P < 0.01. 
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to a lesser extent. After 48 h of culture the 1.5 kb and 
the 5 kb CPCT mRNA reached levels of 300% and 
150%, respectively. The levels of ACC and ACL 
mRNAs increased nearly 2-fold during 35 h of culture, 
although this increase was only statistically significant 
for ACL mRNA. SP-A, SP-B and SP-C mRNAs in- 
creased considerably during the 48 h culture period 
(Fig. 2). After 48 h of culture the SP-B and SP-C 
mRNAs had increased to 600%. while SP-A mRNA had 
reached 2,500% of the original abundance. 
The mRNA encoding p-actin was used as an internal 
control. Its level remained more or less constant during 
culture time (Fig. 1). This indicates that the increases 
seen for the other mRNAs are not due to any non- 
specific effect on mRNAs in general. 
3.2. Effect of dexamethasone on the abundance of the 
mRNAs as a function of culture time 
The effect of dexamethasone on the abundance of the 
various mRNAs was examined as a function of culture 
time. For this purpose explants were exposed to 100 nM 
dexamethasone from the onset of the culture period. 
Previous experiments [6,7] had shown that 100 nM dex- 
amethasone optimally increased the activity of FAS in 
fetal lung explants. At regular intervals explants were 
harvested and the mRNA content was compared with 
that in explants that had been cultured in parallel in the 
absence of dexamethasone. Fig. 3 shows that the abun- 
dance of FAS mRNA was increased significantly by 
dexamethasone during the first 16 h of culture. At 11 h 
of culture a maximal glucocorticoid effect (2.5-fold in- 
crease) was observed. The glucocorticoid effect de- 
creased at later time points. The observation of a dex- 
amethasone-induced increase of FAS mRNA is in 
agreement with an abstract by Palayoor et al. [23], how- 
ever, that group observed the effect after 48 h of culture 
(the only time point studied), while in our experiments 
the glucocorticoid effect was only apparent during the 
first 16 h (Fig. 3). We have no explanation for this 
difference. Contrary to the effect on FAS mRNA, dex- 
amethasone caused a marked decrease of the 3.4 and 2.4 
kb ME mRNAs. This decrease by glucocorticoid was 
already significant after 8 h of culture, while after 48 h 
the abundance of ME mRNA in dexamethasone- 
treated explants was only 20% of that in control ex- 
plants. The mRNAs of CPCT were only slightly influ- 
enced by dexamethasone exposure, although the 5 kb 
mRNA was significantly increased at 16 h and the 1.5 
kb mRNA was significantly depressed at 48 h. Dexa- 
methasone initially had little effect on ACL mRNA, but 
after 24 h a decrease was observed (significant at 24 h 
and 48 h). 
The effect of dexamethasone on SP-A mRNAs as a 
function of culture time was similar to that on FAS 
mRNA (Fig. 4). Dexamethasone caused an increase in 
SP-A mRNA levels during the first 16 h of culture. At 
11 h a maximal lo-fold stimulation was found for the 
1 kb SP-A mRNA. Like for FAS mRNA, the degree of 
glucocorticoid enhancement of SP-A mRNA levels de- 
creased at longer culture times. A similar profile was 
observed for SP-C mRNA, although the magnitude of 
the dexamethasone stimulation was smaller (maximally 
about 2.5-fold) and the variability among experiments 
was larger. For SP-B mRNA there was a significant 
increase by dexamethasone after 16 h of exposure. The 
maximal stimulation (2-fold) was reached after 24 h and 
was maintained up to 48 h. 
Fig. 3 shows that dexamethasone had no significant 
effect on the level of actin mRNA at any time during 
culture, which indicates that the dexamethasone-in- 
duced changes seen for the other mRNAs are not due 
to non-specific effects on mRNAs in general. 
4. DISCUSSION 
In vivo, FAS mRNA in fetal rat lung increases 3-fold 
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Fig. 2. Relatwe abundance of mRNAs encoding surfactant proteins in fetal rat lung explants as a function of culture time. For each experiment 
the abundance of a parttcular mRNA was expressed as a percentage of the abundance at t = 0 h. Data represent means f S.E.M. of 4 independent 
experiments. Significantly different from value at t = 0 h according to Student’s r-test: “0.025 < P < 0.05, “0.01 < P < 0.025. ‘P < 0.01. 
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Fig. 3. Effect of dexamethasone on the abundance of mRNAs encoding liptd synthestzing enzymes and/?-actin in fetal rat lung explants as a function 
of culture time. The abundance of a partrcular mRNA m explants cultured in the presence of dexamethasone is expressed as a percentage of the 
abundance m control explants that had been cultured for the same length of time in the absence of the hormone. Data m the figure represent 
means + SE M. of 3 Independent experiments. Significantly different from no-hormone control according to Student’s t-test: “0.025 < P < 0.05, 
bO.O1 < P < 0.025. 'P < 0.01. The dotted line Indicates the control level. 
between days 18 and 21 [21]. The present study shows 
that in explant culture in the absence of hormones the 
abundance of FAS mRNA increases as it does in vivo 
(Fig. 1). This indicates that factors endogenous to the 
lung can initiate the increase of FAS expression; how- 
ever, the observation that, in addition, dexamethasone 
increases FAS mRNA (Fig. 3) indicates that besides 
endogenous factors, the prenatal surge in glucocorti- 
coids may also be involved in this regulation. 
In fetal rat lung in vivo ME mRNAs do not change 
between days 18 and 22 [21]. Our present results show 
that, by contrast, in explant culture in the absence of 
hormones, ME mRNAs increased considerably in 48 h 
(Fig. 1). This could mean that in vivo the level of ME 
mRNAs, which tends to be increased by factors en- 
dogenous to the lung, is kept in check by a negative 
hormonal control. As we observed that dexamethasone 
could strongly depress the ME mRNA level in the ex- 
plant culture (Fig. 3), it is conceivable that in vivo glu- 
288 
cocorticoid acts as a suppressor of the ME mRNA in- 
crease. For ACL and ACC mRNA the pattern in ex- 
plant culture without hormone (Fig. 1) is very similar 
to the pattern in the fetal lung in vivo [21]. Recently we 
found that the levels of the mRNAs encoding FAS, 
ACC and ACL in fetal type II cells were increased 
approximately 2-fold by glucocorticoid (via interaction 
with fibroblasts), while ME mRNA remained un- 
changed [24]. Although in the present experiments with 
explants FAS mRNA was induced to the same degree, 
this was not the case for the mRNAs of ACC and ACL. 
This might suggest that in the explant system the en- 
hancing effect of glucocorticoid on ACC and ACL 
mRNA in type II cells is suppressed. 
In the late prenatal period there is an increase in the 
activity of CPCT in fetal rat lung [3]. The mechanism 
of the increased activity is not yet clear [3]. Glucocorti- 
coid exposure increases CPCT activity but not CPCT 
amount in fetal lung explants [8]. It has been suggested 
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Fig. 4. Effect of dexamethasone on the abundance of mRNAs encoding surfactant proteins in fetal rat lung explants as a function of culture time. 
The abundance of a particular mRNA in explants cultured in the presence of dexamethasone is expressed as a percentage of the abundance in control 
explants that had been cultured for the same length of time in the absence of the hormone. Data in the figure represent means + S.E.M. of 3 
independent experiments. Significantly different from no-hormone control according to Student’s r-test: “0.025 < P < 0.05, ‘0.01 < P < 0.025, 
‘P < 0.01. The dotted line indicates the control level. 
that the increase in CPCT activity is secondary to the 
induction of fatty acid synthesis by glucocorticoid [8,9]. 
Until now neither the developmental pattern of CPCT 
mRNA in fetal lung in vivo or in explant culture, nor 
the effect of glucocorticoid on CPCT mRNA in fetal 
lung, has been reported. In the present study we ob- 
served a spontaneous increase of CPCT mRNA in cul- 
tured explants (Fig. 1). This could indicate that in vivo 
there is also an increase of CPCT mRNA from day 18 
onward. This idea, however, will have to be corrobo- 
rated by studies in vivo. Glucocorticoid had at best a 
small increasing effect on CPCT mRNA in the explants 
(Fig. 3). A small (fibroblast-mediated) increase of 
CPCT mRNA by glucocorticoid was recently also ob- 
served in fetal type II cells [24]. 
Interestingly, both the spontaneous increase in the 
absence of hormone and the stimulation by dexa- 
methasone show the same pattern for FAS mRNA and 
for SP-A and -C mRNAs (Figs. 14). As for FAS 
mRNA, glucocorticoid increased SP-A and -C mRNAs 
at the beginning of the culture period, when the sponta- 
neous increase of mRNA had not yet started. The sim- 
ilarity in patterns for FAS mRNA and for the surfac- 
tant protein mRNAs might reflect a common regulatory 
mechanism. The spontaneous increase in the mRNAs 
of the three tested surfactant proteins is very similar to 
the pattern observed in fetal rat lung in vivo [25]. A 
spontaneous increase of SP-A mRNA in cultured fetal 
rat lung explants has been reported earlier [26]. To our 
knowledge, such a spontaneous increase in the mRNAs 
for SP-B and SP-C in explant cultures of fetal rat lung 
has not been reported before. For SP-C mRNA in cul- 
tured human lung explants both a small spontaneous 
increase [2] and a 17-fold spontaneous decrease [27] 
have been reported. Our observation that glucocorti- 
coid increases SP-A, -B and -C mRNA in fetal rat lung 
explants agrees with earlier reports [28-301, however, 
detailed comparison of our data concerning the gluco- 
corticoid effects with the earlier reports is difficult due 
to differences in experimental design. In the first place, 
the earlier studies [28-301 involved culture of the ex- 
plants in an atmosphere of 95% 0, It is known that 
oxygen exposure in vivo leads to increased levels of the 
mRNAs of SP-A, -B and -C [31]. Secondly, in the earlier 
studies [28-301 glucocorticoid was not added at the 
onset of the culture experiment but only after various 
preincubation periods in hormone-free medium. 
In summary, the present paper shows that in fetal rat 
lung in explant culture FAS, ACC, ACL, ME, CPCT 
and SP-A, -B and -C are all regulated at a pre-transla- 
tional level, but in different ways. Of the mRNAs for 
lipid synthesizing enzymes, FAS and ME mRNA show 
the most pronounced rise in the absence of hormone, 
while increases in ACC, ACL and CPCT mRNA are 
more modest. Like the mRNAs for the surfactant pro- 
teins, FAS mRNA is considerably increased by dexa- 
methasone exposure, while ME mRNA is severely de- 
pressed. Glucocorticoid has only a small increasing ef- 
fect on CPCT mRNA. The small size of this latter effect 
supports the idea [8,9] that pre-translational regulation 
of the CPCT gene itself is not primarily responsible for 
the increase in CPCT activity observed in fetal lung 
tissue upon glucocorticoid treatment. 
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